Polyplus now part of Sartorius

Polyplus now part of Sartorius

Recherche en biotechnologie

We power your science

À propos

Polyplus, now part of Sartorius is a leading upstream solutions provider for advanced biologic and cell and gene therapy production from research to commercial scale. An innovator in nucleic acid delivery, the legacy portfolio features process-centric transfection reagents, kits, and support services. Custom plasmid vector design was integrated into the offer in 2022 as a first measure to expanding the products and services portfolio to help customers (or the industry) optimize process economics while meeting strict scientific and regulatory standards. Headquartered in Europe, the Polyplus team continues to grow globally with operations in the United States and Asia.

Secteur
Recherche en biotechnologie
Taille de l’entreprise
51-200 employés
Siège social
ILLKIRCH GRAFFENSTADEN
Type
Société civile/Société commerciale/Autres types de sociétés
Domaines
Research, DNA, Transfection, Gene expression, Bioproduction, Life sciences, Biotechnology, RNA interference, Science, Biology, Protein production, Virus production, Cell culture, CRISPR et Biotechnology

Produits

Lieux

Employés chez Polyplus now part of Sartorius

Nouvelles

Pages similaires